Your browser doesn't support javascript.
loading
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
Johnson, J A; Caudle, K E; Gong, L; Whirl-Carrillo, M; Stein, C M; Scott, S A; Lee, M T; Gage, B F; Kimmel, S E; Perera, M A; Anderson, J L; Pirmohamed, M; Klein, T E; Limdi, N A; Cavallari, L H; Wadelius, M.
Afiliación
  • Johnson JA; Department of Pharmacotherapy and Translational Research, College of Pharmacy, and Center for Pharmacogenomics, University of Florida, Gainesville, Florida, USA.
  • Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Gong L; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Stein CM; Division of Clinical Pharmacology Vanderbilt Medical School, Nashville, Tennessee, USA.
  • Scott SA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lee MT; Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; National Center for Genome Medicine; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Genomic Medicine Institute, Geisinger Health system, Danville, Pennsylvan
  • Gage BF; Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Kimmel SE; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Perera MA; Department of Medicine and Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Anderson JL; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Pirmohamed M; Intermountain Heart Institute, Intermountain Medical Center, and Department of Internal Medicine (Cardiology), University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Klein TE; Department of Molecular and Clinical Pharmacology; The Wolfson Centre for Personalised Medicine; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Limdi NA; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Cavallari LH; Department of Neurology and Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Wadelius M; Department of Pharmacotherapy and Translational Research, College of Pharmacy, and Center for Pharmacogenomics, University of Florida, Gainesville, Florida, USA.
Clin Pharmacol Ther ; 102(3): 397-404, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28198005
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Warfarina / Vitamina K Epóxido Reductasas / Citocromo P-450 CYP2C9 / Familia 4 del Citocromo P450 / Anticoagulantes Tipo de estudio: Guideline Límite: Adult / Child / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Warfarina / Vitamina K Epóxido Reductasas / Citocromo P-450 CYP2C9 / Familia 4 del Citocromo P450 / Anticoagulantes Tipo de estudio: Guideline Límite: Adult / Child / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos